Slowakije - Slowaaks - Ecolab

ecolab deutschland gmbh -

Europese Unie - Slowaaks - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastické činidlá - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - viacnásobný myelóm - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - viacnásobný myelóm - antineoplastické činidlá - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

b.braun melsungen ag, nemecko - elektrolyty - 39 - soli a ionty pro p.o. a parent. aplikÁciu

Slowakije - Slowaaks - Ecolab

ecolab deutschland gmbh -